Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioCardia, Inc.BCDA · Entity 7752 | Director | July 06, 2026 | July 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioCardia, Inc.
Report date July 06, 2026 · Filed July 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.20 · Expires 2036-07-06 | Direct | 23,573 |
Reported balance
After 2026-07-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-06 · Grant · Acquired 8,000 · Balance 23,573 F1: One hundred percent of the shares are subject to the option vesting and becoming exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: One hundred percent of the shares are subject to the option vesting and becoming exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 06, 2026 Filed Jul 8, 2026 02:04 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001437749-26-022970 · rdgdoc.xml · derivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,573 Underlying: Common stock · 8,000 shares Expires 2036-07-06 F1 · derivative.exercise_date: One hundred percent of the shares are subject to the option vesting and becoming exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 22:16 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 39,000 | $1.00 | $39,000.00 |
DisclosureSEC source: 0001437749-26-021597 · rdgdoc.xml · nonDerivative · entry 2 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,338 F2 · shares: This transaction was executed in multiple trades ranging from $1.00 to $1.01 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F2 · price: This transaction was executed in multiple trades ranging from $1.00 to $1.01 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 22:16 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 70,200 | $0.92 | $64,584.00 |
DisclosureSEC source: 0001437749-26-021597 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,338 F1 · shares: This transaction was executed in multiple trades ranging from $0.90 to $0.97 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $0.90 to $0.97 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 02:52 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001437749-25-037469 · rdgdoc.xml · derivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,573 Underlying: Common Stock · 12,000 shares Expires 2035-12-08 F1 · derivative.exercise_date: One hundred percent of the shares are subject to the option vesting and becoming exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| September 19, 2025 Filed Sep 23, 2025 13:00 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseWarrant (right to buy) · Derivative | 398,400 | Not disclosed Strike: $1.25 | Not disclosed |
DisclosureSEC source: 0001437749-25-029653 · rdgdoc.xml · derivative · entry 6 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 575,675 Underlying: Common Stock · 398,400 shares Expires 2027-09-20 F1 · shares: These shares were purchased from the Issuer in a public offering that closed on September 19, 2025, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. F1 · price: These shares were purchased from the Issuer in a public offering that closed on September 19, 2025, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. F1 · derivative.underlying_shares: These shares were purchased from the Issuer in a public offering that closed on September 19, 2025, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. F2 · ownership.nature: These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. Read SEC document |
| September 19, 2025 Filed Sep 23, 2025 13:00 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 398,400 | $1.25 | $498,000.00 |
DisclosureSEC source: 0001437749-25-029653 · rdgdoc.xml · nonDerivative · entry 3 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 591,054 F1 · shares: These shares were purchased from the Issuer in a public offering that closed on September 19, 2025, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. F3 · ownership.nature: These shares are held by Windrock Enterprises L.L.C., of which the Reporting Person and his spouse are the sole members and managers. Read SEC document |
| June 30, 2025 Filed Jul 3, 2025 01:02 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseWarrant (right to buy) · Derivative | 72,289 | Not disclosed Strike: $1.95 | Not disclosed |
DisclosureSEC source: 0001437749-25-022063 · rdgdoc.xml · derivative · entry 6 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 177,275 Underlying: Common Stock · 72,289 shares Expires 2030-06-30 F1 · shares: On June 30, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. F1 · price: On June 30, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. F1 · derivative.underlying_shares: On June 30, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. F2 · ownership.nature: These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. Read SEC document |
| June 30, 2025 Filed Jul 3, 2025 01:02 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 72,289 | $2.08 | $149,999.68 |
DisclosureSEC source: 0001437749-25-022063 · rdgdoc.xml · nonDerivative · entry 3 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 192,654 F1 · shares: On June 30, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. F3 · ownership.nature: These shares are held by Windrock Enterprises L.L.C., of which the Reporting Person and his spouse are the sole members and managers. Read SEC document |
| April 23, 2025 Filed Apr 26, 2025 01:35 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseWarrant (right to buy) · Derivative | 104,986 | Not disclosed Strike: $1.91 | Not disclosed |
DisclosureSEC source: 0001437749-25-013197 · rdgdoc.xml · derivative · entry 6 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See note Disclosed balance after: 104,986 Underlying: Common Stock · 104,986 shares Expires 2030-04-23 F1 · shares: On April 23, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. F1 · price: On April 23, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. F1 · derivative.underlying_shares: On April 23, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. Read SEC document |
| April 23, 2025 Filed Apr 26, 2025 01:35 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 104,986 | $1.91 | $199,998.33 |
DisclosureSEC source: 0001437749-25-013197 · rdgdoc.xml · nonDerivative · entry 3 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 120,365 F1 · shares: On April 23, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. F3 · ownership.nature: These shares are held by Windrock Enterprises L.L.C., of which the Reporting Person and his spouse are the sole members and managers. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 13:30 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,000 | $2.45 | $2,450.00 |
DisclosureSEC source: 0001437749-25-006561 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,138 Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 13:30 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 15,536 | $2.30 | $35,732.80 |
DisclosureSEC source: 0001437749-25-006221 · rdgdoc.xml · nonDerivative · entry 2 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,138 F2 · price: This transaction was executed in multiple trades ranging from $2.34 to $2.50 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 13:30 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 22,753 | $2.30 | $52,331.90 |
DisclosureSEC source: 0001437749-25-006221 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,602 F1 · price: This transaction was executed in multiple trades ranging from $2.13 to $2.50 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| October 11, 2024 Filed Oct 17, 2024 01:55 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantStock Option (right to buy) · Derivative | 829 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001437749-24-031407 · rdgdoc.xml · derivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,573 Underlying: Common stock · 829 shares Expires 2034-10-11 F1 · derivative.exercise_date: One hundred percent of the shares subject to the option vest and become exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| October 18, 2023 Filed Oct 19, 2023 21:02 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantStock Option (right to buy) · Derivative | 12,434 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001437749-23-028619 · rdgdoc.xml · derivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,510 Underlying: Common stock · 12,434 shares Expires 2033-10-18 F1 · derivative.exercise_date: One hundred percent of the shares subject to the option vest and become exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| June 23, 2023 Filed Jun 27, 2023 00:25 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 64,212 | $2.34 | $149,999.23 |
DisclosureSEC source: 0001437749-23-018549 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267,766 F1 · shares: These shares were purchased from the Issuer in a registered direct offering that closed on June 23, 2023. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 13:01 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 178,571 | $1.68 | $299,999.28 |
DisclosureSEC source: 0001437749-22-029315 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 888,084 F1 · shares: These shares were purchased from the Issuer in a private placement that closed on December 16, 2022. F2 · ownership.nature: These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. Read SEC document |
| June 10, 2022 Filed Sep 30, 2022 21:01 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantStock Option (right to buy) · Derivative | 12,434 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0001437749-22-023322 · rdgdoc.xml · derivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,076 Underlying: Common stock · 12,434 shares Expires 2032-06-10 F1 · derivative.exercise_date: One hundred percent of the shares subject to the option vest and become exercisable on the one-year anniversary of the date of grant. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 00:49 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantStock Option (right to buy) · Derivative | 12,434 | $0.00 Strike: $4.43 | $0.00 |
DisclosureSEC source: 0001437749-21-014882 · rdgdoc.xml · derivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,642 Underlying: Common stock · 12,434 shares Expires 2031-06-15 F1 · derivative.exercise_date: One hundred percent of the shares subject to the option vest and become exercisable on the one-year anniversary of the date of grant. Read SEC document |
| March 31, 2021 Filed Apr 8, 2021 00:21 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 2,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-008503 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,554 F1 · shares: The award relates to vested restricted stock units ("RSUs") granted March 31, 2021, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (i) two years from the date of grant, (ii) the date the director ceases to be a service provider, or (iii) such other date as the administrator determines under the Issuer's 2016 Equity Incentive Plan. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 02:54 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 2,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-000196 · rdgdoc.xml · nonDerivative · entry 2 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,250 F1 · shares: The award relates to vested restricted stock units ("RSUs") granted December 31, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (i) two years from the date of grant, (ii) the date the director ceases to be a service provider, or (iii) such other date as the administrator determines under the Issuer's 2016 Equity Incentive Plan. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 02:54 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 2,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-000196 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,282 F1 · shares: The award relates to vested restricted stock units ("RSUs") granted December 31, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (i) two years from the date of grant, (ii) the date the director ceases to be a service provider, or (iii) such other date as the administrator determines under the Issuer's 2016 Equity Incentive Plan. Read SEC document |
| September 30, 2020 Filed Oct 9, 2020 23:12 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 2,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-021021 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,482 F1 · shares: The award relates to vested restricted stock units ("RSUs") granted September 30, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (i) two years from the date of grant, (ii) the date the director ceases to be a service provider, or (iii) such other date as the administrator determines under the Issuer's 2016 Equity Incentive Plan. Read SEC document |
| June 30, 2020 Filed Jul 1, 2020 20:54 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 4,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-014383 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,514 F1 · shares: The award relates to vested restricted stock units ("RSUs") granted June 30, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (i) two years from the date of grant, (ii) the date the director ceases to be a service provider, or (iii) such other date as the administrator determines under the Issuer's 2016 Equity Incentive Plan. Read SEC document |
| June 19, 2020 Filed Jun 24, 2020 01:21 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseCommon Stock | 142,850 | $2.10 | $299,985.00 |
DisclosureSEC source: 0001437749-20-013717 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,983 F1 · shares: These shares were purchased from the underwriters in a firm-commitment underwritten public offering of shares of the Issuer's common stock that closed on June 19, 2020. Read SEC document |
| May 08, 2020 Filed May 21, 2020 01:36 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 8,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-011486 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,133 F1 · shares: The award relates to vested restricted stock units ("RSUs") granted May 8, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (1) the two (2) year anniversary of the grant date; (3) the Reporting Person's separation from service; (3) a change in control, as defined in the Issuer's 2016 Equity Incentive Plan; or (4) the Reporting Person's death. Read SEC document |
| April 30, 2020 Filed May 5, 2020 01:31 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 4,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-009334 · rdgdoc.xml · nonDerivative · entry 2 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,739 F1 · shares: The award relates to vested restricted stock units ("RSUs") granted April 30, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (i) two years from the date of grant, (ii) the date the director ceases to be a service provider, or (iii) such other date as the administrator determines under the Issuer's 2016 Equity Incentive Plan. Read SEC document |
| April 30, 2020 Filed May 5, 2020 01:31 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 26,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-009334 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,208 F1 · shares: The award relates to vested restricted stock units ("RSUs") granted April 30, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (i) two years from the date of grant, (ii) the date the director ceases to be a service provider, or (iii) such other date as the administrator determines under the Issuer's 2016 Equity Incentive Plan. Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 01:46 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseWarrant (right to buy) · Derivative | 67,484 | Not disclosed Strike: $6.30 | Not disclosed |
DisclosureSEC source: 0001437749-19-015681 · rdgdoc.xml · derivative · entry 10 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 234,150 Underlying: Common Stock · 67,484 shares Expires 2024-08-06 F1 · shares: These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offering in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consists of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit. F1 · price: These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offering in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consists of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit. F1 · derivative.underlying_shares: These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offering in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consists of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit. F2 · ownership.nature: These securities are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 01:46 UTC | BioCardia, Inc. BCDA · Entity 7752 | ConversionConvertible promissory note · Derivative | Not disclosed | $0.00 Strike: $3.00 | $200,000.00 |
DisclosureSEC source: 0001437749-19-015681 · rdgdoc.xml · derivative · entry 9 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 67,484 shares Expires 2020-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offering in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consists of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit. F1 · reported_value: These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offering in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consists of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit. F1 · derivative.underlying_shares: These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offering in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consists of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit. F2 · ownership.nature: These securities are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 01:46 UTC | BioCardia, Inc. BCDA · Entity 7752 | ConversionCommon Stock | 67,484 | $3.00 | $202,452.00 |
DisclosureSEC source: 0001437749-19-015681 · rdgdoc.xml · nonDerivative · entry 2 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 709,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offering in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consists of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit. F2 · balance_after: These securities are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. F2 · ownership.nature: These securities are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. Read SEC document |
| August 02, 2019 Filed Aug 7, 2019 01:46 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseWarrant (right to buy) · Derivative | 166,666 | Not disclosed Strike: $6.30 | Not disclosed |
DisclosureSEC source: 0001437749-19-015681 · rdgdoc.xml · derivative · entry 8 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 166,666 Underlying: Common Stock · 166,666 shares Expires 2024-08-06 F3 · shares: The reported securities were included within 166,666 units purchased by the Stertzer Family Trust for $6.00 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock. F3 · price: The reported securities were included within 166,666 units purchased by the Stertzer Family Trust for $6.00 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock. F2 · ownership.nature: These securities are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. Read SEC document |
| August 02, 2019 Filed Aug 7, 2019 01:46 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 166,666 | $6.00 | $999,996.00 |
DisclosureSEC source: 0001437749-19-015681 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 642,029 F3 · shares: The reported securities were included within 166,666 units purchased by the Stertzer Family Trust for $6.00 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock. F2 · ownership.nature: These securities are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. Read SEC document |
| August 02, 2019 Filed May 21, 2020 01:24 UTC Amendment | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseWarrant (right to buy) · Derivative | 41,667 | Not disclosed Strike: $6.30 | Not disclosed |
DisclosureSEC source: 0001437749-20-011485 · rdgdoc.xml · derivative · entry 2 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 41,667 Underlying: Common Stock · 41,667 shares Expires 2024-08-06 F1 · shares: The original Form 4 omitted the issuance of these securities. F2 · price: The reported securities were included within 41,667 units purchased by Stertzer Holdings LLC for $6.00 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock. F3 · ownership.nature: These securities are held by Stertzer Holdings LLC, and the Reporting Person may be deemed to have beneficial ownership of such securities. Read SEC document |
| August 02, 2019 Filed May 21, 2020 01:24 UTC Amendment | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseCommon Stock | 41,667 | $6.00 | $250,002.00 |
DisclosureSEC source: 0001437749-20-011485 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 91,544 F1 · shares: The original Form 4 omitted the issuance of these securities. F2 · shares: The reported securities were included within 41,667 units purchased by Stertzer Holdings LLC for $6.00 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock. F3 · ownership.nature: These securities are held by Stertzer Holdings LLC, and the Reporting Person may be deemed to have beneficial ownership of such securities. Read SEC document |
| July 26, 2019 Filed Aug 23, 2019 10:36 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | Exercise / conversionRestricted Stock Units · Derivative | 3,594 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-017337 · rdgdoc.xml · derivative · entry 7 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,594 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019), which vested on July 26, 2019. The common stock into which such vested RSUs converted on July 26, 2019 is reported on Table I of this Form 4. F4 · derivative.expiration_date: On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019), which vested on July 26, 2019. The common stock into which such vested RSUs converted on July 26, 2019 is reported on Table I of this Form 4. Read SEC document |
| July 26, 2019 Filed Aug 23, 2019 10:36 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | Exercise / conversionCommon Stock | 3,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-017337 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of RSUs into common stock. On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019) that were previously reported on Table II of Form 4, which form was filed with the SEC on September 26, 2018. F2 · price: The converted RSU corresponds to a 1:1 common stock issuance. Read SEC document |
| July 05, 2019 Filed Aug 7, 2019 01:46 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseConvertible promissory note · Derivative | Not disclosed | $200,000.00 Strike: $8.00 | $200,000.00 |
DisclosureSEC source: 0001437749-19-015681 · rdgdoc.xml · derivative · entry 7 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: Not disclosed Underlying: Common Stock · 25,000 shares Expires 2020-06-05 F1 · derivative.exercise_price: These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offering in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consists of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit. F1 · reported_value: These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offering in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consists of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit. F1 · derivative.underlying_shares: These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offering in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consists of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit. F2 · ownership.nature: These securities are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. Read SEC document |
| December 24, 2018 Filed Dec 27, 2018 20:51 UTC Amendment | BioCardia, Inc. BCDA · Entity 7752 | PurchaseWarrant (right to buy) · Derivative | 833,333 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001437749-18-022658 · rdgdoc.xml · derivative · entry 7 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 833,333 Underlying: Common Stock · 833,333 shares Expires 2023-12-24 F1 · shares: On December 24, 2018, the Issuer entered into a Securities Purchase Agreement with certain investors whereby the Stertzer Family Trust and Windrock Enterprises L.L.C. each purchased 1,666,666 shares of Common Stock of the Issuer and a warrant to purchase 833,333 shares of Common Stock of the Issuer with an exercise price of $0.75 per share. F3 · ownership.nature: These securities are held by Windrock Enterprises L.L.C., of which the Reporting Person and his spouse are the sole members and managers. Read SEC document |
| December 24, 2018 Filed Dec 27, 2018 20:51 UTC Amendment | BioCardia, Inc. BCDA · Entity 7752 | PurchaseWarrant (right to buy) · Derivative | 833,333 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001437749-18-022658 · rdgdoc.xml · derivative · entry 6 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 833,333 Underlying: Common Stock · 833,333 shares Expires 2023-12-24 F1 · shares: On December 24, 2018, the Issuer entered into a Securities Purchase Agreement with certain investors whereby the Stertzer Family Trust and Windrock Enterprises L.L.C. each purchased 1,666,666 shares of Common Stock of the Issuer and a warrant to purchase 833,333 shares of Common Stock of the Issuer with an exercise price of $0.75 per share. F2 · ownership.nature: These securities are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. Read SEC document |
| December 24, 2018 Filed Dec 27, 2018 20:51 UTC Amendment | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon stock | 1,666,666 | $0.75 | $1,249,999.50 |
DisclosureSEC source: 0001437749-18-022658 · rdgdoc.xml · nonDerivative · entry 2 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,076,346 F1 · shares: On December 24, 2018, the Issuer entered into a Securities Purchase Agreement with certain investors whereby the Stertzer Family Trust and Windrock Enterprises L.L.C. each purchased 1,666,666 shares of Common Stock of the Issuer and a warrant to purchase 833,333 shares of Common Stock of the Issuer with an exercise price of $0.75 per share. F3 · ownership.nature: These securities are held by Windrock Enterprises L.L.C., of which the Reporting Person and his spouse are the sole members and managers. Read SEC document |
| December 24, 2018 Filed Dec 27, 2018 20:51 UTC Amendment | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,666,666 | $0.75 | $1,249,999.50 |
DisclosureSEC source: 0001437749-18-022658 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,283,275 F1 · shares: On December 24, 2018, the Issuer entered into a Securities Purchase Agreement with certain investors whereby the Stertzer Family Trust and Windrock Enterprises L.L.C. each purchased 1,666,666 shares of Common Stock of the Issuer and a warrant to purchase 833,333 shares of Common Stock of the Issuer with an exercise price of $0.75 per share. F2 · ownership.nature: These securities are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. Read SEC document |
| December 24, 2018 Filed Dec 27, 2018 19:34 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseWarrant (right to buy) · Derivative | 833,333 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001437749-18-022644 · rdgdoc.xml · derivative · entry 7 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 833,333 Underlying: Common Stock · 833,333 shares Expires 2023-12-24 F1 · shares: On December 24, 2018, the Issuer entered into a Securities Purchase Agreement with certain investors whereby the Stertzer Family Trust and Windrock Enterprises L.L.C. each purchased 1,666,666 shares of Common Stock of the Issuer and a warrant to purchase 833,333 shares of Common Stock of the Issuer with an exercise price of $0.75 per share. F3 · ownership.nature: These securities are held by Windrock Enterprises L.L.C., of which the Reporting Person and his spouse are the sole members and managers. Read SEC document |
| December 24, 2018 Filed Dec 27, 2018 19:34 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseWarrant (right to buy) · Derivative | 833,333 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001437749-18-022644 · rdgdoc.xml · derivative · entry 6 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 833,333 Underlying: Common Stock · 833,333 shares Expires 2023-12-24 F1 · shares: On December 24, 2018, the Issuer entered into a Securities Purchase Agreement with certain investors whereby the Stertzer Family Trust and Windrock Enterprises L.L.C. each purchased 1,666,666 shares of Common Stock of the Issuer and a warrant to purchase 833,333 shares of Common Stock of the Issuer with an exercise price of $0.75 per share. F2 · ownership.nature: These securities are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. Read SEC document |
| December 24, 2018 Filed Dec 27, 2018 19:34 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon stock | 1,666,666 | $0.75 | $1,249,999.50 |
DisclosureSEC source: 0001437749-18-022644 · rdgdoc.xml · nonDerivative · entry 2 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,076,346 F1 · shares: On December 24, 2018, the Issuer entered into a Securities Purchase Agreement with certain investors whereby the Stertzer Family Trust and Windrock Enterprises L.L.C. each purchased 1,666,666 shares of Common Stock of the Issuer and a warrant to purchase 833,333 shares of Common Stock of the Issuer with an exercise price of $0.75 per share. F3 · ownership.nature: These securities are held by Windrock Enterprises L.L.C., of which the Reporting Person and his spouse are the sole members and managers. Read SEC document |
| December 24, 2018 Filed Dec 27, 2018 19:34 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,666,666 | $0.75 | $1,249,999.50 |
DisclosureSEC source: 0001437749-18-022644 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,283,275 F1 · shares: On December 24, 2018, the Issuer entered into a Securities Purchase Agreement with certain investors whereby the Stertzer Family Trust and Windrock Enterprises L.L.C. each purchased 1,666,666 shares of Common Stock of the Issuer and a warrant to purchase 833,333 shares of Common Stock of the Issuer with an exercise price of $0.75 per share. F2 · ownership.nature: These securities are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. Read SEC document |
| December 24, 2018 Filed Jan 4, 2019 02:52 UTC Amendment | BioCardia, Inc. BCDA · Entity 7752 | PurchaseWarrant (right to buy) · Derivative | 833,333 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001437749-19-000286 · rdgdoc.xml · derivative · entry 7 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 833,333 Underlying: Common Stock · 833,333 shares Expires 2023-12-24 F1 · shares: On December 24, 2018, the Issuer entered into a Securities Purchase Agreement with certain investors whereby the Stertzer Family Trust and Windrock Enterprises L.L.C. each purchased 1,666,666 shares of Common Stock of the Issuer and a warrant to purchase 833,333 shares of Common Stock of the Issuer with an exercise price of $0.75 per share. F3 · ownership.nature: These securities are held by Windrock Enterprises L.L.C., of which the Reporting Person and his spouse are the sole members and managers. Read SEC document |
| December 24, 2018 Filed Jan 4, 2019 02:52 UTC Amendment | BioCardia, Inc. BCDA · Entity 7752 | PurchaseWarrant (right to buy) · Derivative | 833,333 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001437749-19-000286 · rdgdoc.xml · derivative · entry 6 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 833,333 Underlying: Common Stock · 833,333 shares Expires 2023-12-24 F1 · shares: On December 24, 2018, the Issuer entered into a Securities Purchase Agreement with certain investors whereby the Stertzer Family Trust and Windrock Enterprises L.L.C. each purchased 1,666,666 shares of Common Stock of the Issuer and a warrant to purchase 833,333 shares of Common Stock of the Issuer with an exercise price of $0.75 per share. F2 · ownership.nature: These securities are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. The aggregate amount of shares reported as beneficially owned by the Stertzer Family Trust was incorrect in Form 4s previously reported due to mathematical errors and the erroneous attributions of purchases made by Dr. Stertzer directly as reported on the Reporting Person's Form 4s filed on September 20, 2018 for the purchase of 5,000 shares and on September 24, 2018 for the purchase of 1,000 shares Read SEC document |
| December 24, 2018 Filed Jan 4, 2019 02:52 UTC Amendment | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,666,666 | $0.75 | $1,249,999.50 |
DisclosureSEC source: 0001437749-19-000286 · rdgdoc.xml · nonDerivative · entry 2 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,076,346 F1 · shares: On December 24, 2018, the Issuer entered into a Securities Purchase Agreement with certain investors whereby the Stertzer Family Trust and Windrock Enterprises L.L.C. each purchased 1,666,666 shares of Common Stock of the Issuer and a warrant to purchase 833,333 shares of Common Stock of the Issuer with an exercise price of $0.75 per share. F3 · ownership.nature: These securities are held by Windrock Enterprises L.L.C., of which the Reporting Person and his spouse are the sole members and managers. Read SEC document |
| December 24, 2018 Filed Jan 4, 2019 02:52 UTC Amendment | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,666,666 | $0.75 | $1,249,999.50 |
DisclosureSEC source: 0001437749-19-000286 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,278,274 F1 · shares: On December 24, 2018, the Issuer entered into a Securities Purchase Agreement with certain investors whereby the Stertzer Family Trust and Windrock Enterprises L.L.C. each purchased 1,666,666 shares of Common Stock of the Issuer and a warrant to purchase 833,333 shares of Common Stock of the Issuer with an exercise price of $0.75 per share. F2 · balance_after: These securities are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. The aggregate amount of shares reported as beneficially owned by the Stertzer Family Trust was incorrect in Form 4s previously reported due to mathematical errors and the erroneous attributions of purchases made by Dr. Stertzer directly as reported on the Reporting Person's Form 4s filed on September 20, 2018 for the purchase of 5,000 shares and on September 24, 2018 for the purchase of 1,000 shares F2 · ownership.nature: These securities are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. The aggregate amount of shares reported as beneficially owned by the Stertzer Family Trust was incorrect in Form 4s previously reported due to mathematical errors and the erroneous attributions of purchases made by Dr. Stertzer directly as reported on the Reporting Person's Form 4s filed on September 20, 2018 for the purchase of 5,000 shares and on September 24, 2018 for the purchase of 1,000 shares Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.